These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 6290927)
1. Trial of an ACTH4-9 Analogue (ORG 2766) in children with intractable seizures. Pentella K; Bachman DS; Sandman CA Neuropediatrics; 1982 May; 13(2):59-62. PubMed ID: 6290927 [TBL] [Abstract][Full Text] [Related]
2. A comparative study of the efficacy of ACTH4-9 analog, methylphenidate, and placebo on attention deficit disorder with hyperkinesis. Butter HJ; Lapierre Y; Firestone P; Blank A J Clin Psychopharmacol; 1983 Aug; 3(4):226-30. PubMed ID: 6309918 [TBL] [Abstract][Full Text] [Related]
3. [Anticonvulsive properties of peptide ACTH4-7 pro-gly-pro detected in amygdaloid kindling and audiogenic epilepsy in rats]. Chepurnov SA; Chepurnova NE; Artiukhova MV; Kuznetsova EIu; Nezavibat'ko VN Biull Eksp Biol Med; 1989 Jun; 107(6):702-4. PubMed ID: 2551416 [TBL] [Abstract][Full Text] [Related]
4. Adrenocorticotropic hormone versus pulsatile dexamethasone in the treatment of infantile epilepsy syndromes. Haberlandt E; Weger C; Sigl SB; Rauchenzauner M; Scholl-Bürgi S; Rostásy K; Karall D Pediatr Neurol; 2010 Jan; 42(1):21-7. PubMed ID: 20004858 [TBL] [Abstract][Full Text] [Related]
5. Use of risperidone in children with epilepsy. Holzhausen SP; Guerreiro MM; Baccin CE; Montenegro MA Epilepsy Behav; 2007 May; 10(3):412-6. PubMed ID: 17382594 [TBL] [Abstract][Full Text] [Related]
7. Rationale for the use of the ACTH4-9 analogue ORG 2766 in the treatment of diabetic neuropathy. Bravenboer B; Erkelens DW; Gispen WH Neth J Med; 1992 Dec; 41(5-6):255-8. PubMed ID: 1337372 [No Abstract] [Full Text] [Related]
8. [Effects of synthetic neuropeptides in psycho-organic brain syndrome. Results with ACTH4-10 and ACTH4-9-analog (author's transl)]. Schneider E; Jacobi P; van Riezen H; Voerman JW; Fischer PA Pharmacopsychiatria; 1981 Sep; 14(5):155-9. PubMed ID: 6270708 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of pyridoxine dependent seizures in south Indian children with early onset intractable epilepsy: A hospital based prospective study. Ramachandrannair R; Parameswaran M Eur J Paediatr Neurol; 2005; 9(6):409-13. PubMed ID: 16257246 [TBL] [Abstract][Full Text] [Related]
10. [Use of synthetic ACTH (Synacthen depot) in the treatment of various forms of epilepsy in children]. Brambilla F; Giardini M; Lenti C Riv Neurol; 1972; 42(6):542-51. PubMed ID: 4348763 [No Abstract] [Full Text] [Related]
11. The frequency of intractable seizures after stopping AEDs in seizure-free children with epilepsy. Camfield P; Camfield C Neurology; 2005 Mar; 64(6):973-5. PubMed ID: 15781810 [TBL] [Abstract][Full Text] [Related]
12. Pyridoxal phosphate is better than pyridoxine for controlling idiopathic intractable epilepsy. Wang HS; Kuo MF; Chou ML; Hung PC; Lin KL; Hsieh MY; Chang MY Arch Dis Child; 2005 May; 90(5):512-5. PubMed ID: 15851435 [TBL] [Abstract][Full Text] [Related]
13. Combination therapy with albendazole and praziquantel versus albendazole alone in children with seizures and single lesion neurocysticercosis: a randomized, placebo-controlled double blind trial. Kaur S; Singhi P; Singhi S; Khandelwal N Pediatr Infect Dis J; 2009 May; 28(5):403-6. PubMed ID: 19325515 [TBL] [Abstract][Full Text] [Related]
14. Fasting versus gradual initiation of the ketogenic diet: a prospective, randomized clinical trial of efficacy. Bergqvist AG; Schall JI; Gallagher PR; Cnaan A; Stallings VA Epilepsia; 2005 Nov; 46(11):1810-9. PubMed ID: 16302862 [TBL] [Abstract][Full Text] [Related]
15. [Changes of cortisolemia during ACTH therapy in subjects with convulsive encephalopathies]. Zammarchi E; Pierro U Riv Clin Pediatr; 1968; 81(3):298-301. PubMed ID: 4310705 [No Abstract] [Full Text] [Related]
16. The effect of Nigella sativa L. (black cumin seed) on intractable pediatric seizures. Akhondian J; Parsa A; Rakhshande H Med Sci Monit; 2007 Dec; 13(12):CR555-9. PubMed ID: 18049435 [TBL] [Abstract][Full Text] [Related]
17. Longitudinal assessment of adaptive behavior in infants and young children with newly diagnosed epilepsy: influences of etiology, syndrome, and seizure control. Berg AT; Smith SN; Frobish D; Beckerman B; Levy SR; Testa FM; Shinnar S Pediatrics; 2004 Sep; 114(3):645-50. PubMed ID: 15342834 [TBL] [Abstract][Full Text] [Related]
18. Dose-response study of vigabatrin in children with refractory epilepsy. Herranz JL; Arteaga R; Farr IN; Valdizan E; Beaumont D; Armijo JA J Child Neurol; 1991; Suppl 2():S45-51. PubMed ID: 1940124 [TBL] [Abstract][Full Text] [Related]
19. Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy. Shinnar S; Pellock JM; Conry JA Eur J Paediatr Neurol; 2009 Jan; 13(1):3-9. PubMed ID: 18343174 [TBL] [Abstract][Full Text] [Related]
20. Melatonin in wake-sleep disorders in children, adolescents and young adults with mental retardation with or without epilepsy: a double-blind, cross-over, placebo-controlled trial. Coppola G; Iervolino G; Mastrosimone M; La Torre G; Ruiu F; Pascotto A Brain Dev; 2004 Sep; 26(6):373-6. PubMed ID: 15275698 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]